Kaitlin Colella, PA
Medical · Windermere, FLNPI 1437570827
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,688 of the $17,668 with a category attached, or 60.5%. QOL Medical, LLC accounts for 62.9% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2021 at $12,376 and has fallen 90.8% since, to $1,142 in 2025. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 245 payments — averaging $72.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- QOL Medical, LLC$11K
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$364
- Ardelyx, Inc.$340
- plus $2K from 20 others
What the payments were for
- Consulting fees$2251%
- Speaking & faculty fees$10,68860%
- Travel & lodging$170%
- Food & beverage$6,37736%
- Education$3622%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| QOL Medical, LLC | 29 | $11,122 |
| AbbVie | 72 | $1,321 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 37 | $1,190 |
| Johnson & Johnson | 21 | $1,009 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $364 |
| Ardelyx, Inc. | 3 | $340 |
| Pfizer | 14 | $261 |
| Intercept Pharmaceuticals, Inc. | 6 | $235 |
| Bristol Myers Squibb | 9 | $196 |
| Sanofi | 3 | $156 |
| Madrigal Pharmaceuticals | 1 | $146 |
| Lucid Diagnostics Inc. | 2 | $140 |
| Janssen Scientific Affairs, LLC | 2 | $135 |
| Mallinckrodt Hospital Products Inc. | 1 | $118 |
| Phathom Pharmaceuticals, Inc. | 1 | $116 |
| Gilead | 3 | $113 |
| E.r. Squibb & Sons, L.L.C. | 1 | $108 |
| Celltrion USA Inc. | 1 | $97 |
| Ironwood Pharmaceuticals, Inc | 4 | $87 |
| Vivus LLC | 4 | $86 |
| Ferring Pharmaceuticals Inc. | 3 | $80 |
| Nestle Healthcare Nutrition Inc. | 4 | $72 |
| Daiichi Sankyo Inc. | 4 | $62 |
| Amgen | 2 | $56 |
| Merck | 2 | $40 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,668 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Windermere
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.